Clinical Trial

Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

Study acronym: OVHIPEC-2
Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
stage III epithelial ovarian cancer randomizing between primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2018-12-10; most recent amendment 2026-04-02.
Status change: Recruiting → Active, Not Recruiting 2026-04-02
Status change: Not Yet Recruiting → Recruiting 2021-05-31
Trial Details
NCT Number NCT03772028
Lead Sponsor The Netherlands Cancer Institute
Conditions Ovarian Cancer
Enrollment 538 participants
Start Date 2020-01-01
Primary Completion 2028-04-01 (estimated)
Study Completion 2028-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-08